| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | 10% Owner | Director, 10% Owner
36 companies
Orbimed Advisors LLC is a Director, 10% Owner at EWTX with holdings across 36 companies. Recent SEC Form 4 filings include 6 buys and 13 sells.
Estimated insider holdings value: $1500.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | SCTX Scribe Therapeutics Inc. | Director | Buy | 1,000,000 | $15.00 | $15,000,000.00 | +286.7% | - | - | |
| Jul 7, 2026 | SION Sionna Therapeutics, Inc. | Director | Sell | 85,918 | $44.86 | $3,854,281.48 | -3.4% | - | - | |
| Jun 15, 2026 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Sell | 281,408 | $45.02 | $12,668,988.16 | -3.6% | - | - | |
| May 28, 2026 | QTTB Q32 Bio Inc. | Director, 10% Owner | Buy | 1,875,000 | $8.00 | $15,000,000.00 | +83.2% | - | - | |
| May 27, 2026 | SION Sionna Therapeutics, Inc. | Director | Sell | 101 | $44.49 | $4,493.49 | - | - | - | |
| Apr 21, 2026 | PRLD Prelude Therapeutics Incorporated | Director, 10% Owner | Buy | 2,815,315 | $4.44 | $12,499,998.60 | +27.8% | -9.5% | - | |
| Apr 18, 2026 | SION Sionna Therapeutics, Inc. | Director | Sell | 55,345 | $44.67 | $2,472,342.92 | -0.9% | +4.0% | - | |
| Apr 16, 2026 | TRAW Traws Pharma, Inc. | 10% Owner | Buy | 597,729 | $1.67 | $998,207.43 | +98.7% | -46.3% | - | |
| Apr 16, 2026 | SION Sionna Therapeutics, Inc. | Director | Sell | 510,583 | $44.94 | $22,945,043.50 | -5.0% | -1.9% | - | |
| Apr 8, 2026 | ACET Adicet Bio, Inc. | 10% Owner | Sell | 104,658 | $6.45 | $674,847.06 | -60.8% | +31.3% | - |